Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Nephro-Urology Monthly
  4. Articles

  5. Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal Transplantation
  6. Scopus by Title (Ref)

Nephro-Urology Monthly

Home
Current IssueAll IssuesIn PressSearchAccepted Manuscripts
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesPublication Ethics and Malpractice StatementSupportReviewer and AE Registration FormContact UsJournal MetricsOpen Peer Review (OPR)
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Peptides, antibodies, peptide antibodies and more

- Trier N. , et al.

2. Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation

- Nowacki M. , et al.

3. Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients

- Yamada C. , et al.

4. Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis

- Schwab N. , et al.

5. Drugs derived from biotechnology, the future starts now

- Machado-Alba J. , et al.

6. Induction of PD-L1 on monocytes: A new mechanism by which IVIg inhibits mixed lymphocyte reactions

- Padet L. , et al.

7. Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: Approved therapies and emerging candidates

- Dubey D. , et al.

8. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells

- Schneider-Hohendorf T. , et al.

9. Application of daclizumab as an immune induction therapy after liver transplantation

- Liu Y. , et al.

10. Efficacy of anti-interleukin-2 receptor antibody in reducing the incidence of acute rejection after renal transplantation

- Liborio A.B. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Publication Ethics and Malpractice Statement
  • Support
  • Reviewer and AE Registration Form
  • Contact Us
  • Journal Metrics
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.